53 studies found for:    SDF-1
Show Display Options
Rank Status Study
1 Recruiting Dynamic Changes in SDF-1α Levels in Acute and Stabilized Heart Disease
Conditions: Atrial Fibrillation;   Ischemic Heart Disease;   Congestive Heart Failure
Intervention: Other: DYNASDY
2 Recruiting Circulating Stem Cells, SDF-1, HIF-1 and Sepsis's Indices in Emergency Abdominal Surgical Patients
Condition: Sepsis
Intervention:
3 Unknown  The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma
Condition: Oral Cancer
Intervention:
4 Unknown  Functional Improvement of Progenitor Cells and Endothelial Function by Vildagliptin in Diabetes Mellitus (FINNjA-DM).
Condition: SDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV Inhibitors
Intervention: Drug: Vildagliptin
5 Unknown  The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma
Conditions: Laryngeal Cancer;   Hypopharyngeal Cancer;   Metastasis
Intervention:
6 Recruiting The Impact of Glucose Lowering Therapies on Circulating Endothelial Progenitor Cells and Its Mobilising Factor Stromal Derived Factor-1α in Patients With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Cardiovascular Diseases
Intervention:
7 Recruiting Linagliptin and Mesenchymal Stem Cells: A Pilot Study
Condition: Schizophrenia
Intervention: Drug: Linagliptin
8 Completed Effect of Sitagliptin on Endothelial Progenitor Cells
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Sitagliptin
9 Recruiting SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease
Condition: Peripheral Arterial Disease
Interventions: Biological: JVS-100;   Biological: Placebo
10 Completed Adiponectin and Circulating Progenitor Cells (CPC) Function
Condition: Coronary Artery Disease
Intervention: Other: exercise training
11 Unknown  Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML)
Condition: Acute Myeloid Leukemia
Interventions: Drug: plerixafor;   Drug: decitabine
12 Completed AMD3100 to Mobilize Stem Cells for Donation
Conditions: Healthy;   Blood Component Removal
Intervention: Drug: AMD3100
13 Terminated Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients
Conditions: Hepatocellular Cancer;   Non-small Cell Lung Cancer;   Renal Cell Cancer;   Colorectal Cancer
Interventions: Drug: Avastin;   Drug: Suntent;   Drug: Nexavar
14 Recruiting Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Condition: T-Lymphocytopenia, Idiopathic CD4-Positive
Intervention:
15 Recruiting Correlation of CXCR4 Expression in Premature Infants With a Diagnosis of Autism at 24 Months
Conditions: Autism Spectrum Disorder;   Complication of Prematurity
Intervention:
16 Terminated Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation
Conditions: Chronic Lymphocytic Leukemia;   Lymphoma;   Multiple Myeloma
Intervention: Drug: Plerixafor
17 Active, not recruiting The Role of Fibrocytes in Acute Lung Injury
Condition: Acute Lung Injury(ALI)
Intervention:
18 Completed
Has Results
Study on the Efficacy and Mechanism of Cardiac Rehabilitation for Stem Cell Mobilization and Heart Failure Improvement
Condition: Myocardial Infarction
Intervention: Behavioral: cardiac rehabilitation
19 Completed A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation
Conditions: Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Chronic Myeloid Leukemia;   Myelodysplastic Syndrome;   Non-Hodgkin's Lymphoma
Intervention: Drug: Plerixafor
20 Active, not recruiting Phase I, Arteriocyte Magellan MAR01 Therapy - Compartment Syndrome and Battlefield Trauma
Condition: Compartment Syndrome
Intervention: Device: Magellan®

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.